Windtree Therapeutics Inc.

13F holders, Q4 2024 (December 31)
15holders +7
9new positions
3sold out
1famous investor
$0.35avg. 13F price*

At the end of Q4 2024, 15 institutions reported holding Windtree Therapeutics Inc. in their 13F filings, up 7 from Q3 2024. 9 opened new positions and 3 sold out. The largest holders were Renaissance Technologies ($42K), UBS Group AG ($21K) and Geode Capital Management, LLC ($21K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Windtree Therapeutics Inc.
CUSIP
97382D501
Latest filing quarter
Q4 2024

History

Number of 13F holders

051015 Q2 2024: 5Q2 2024Q3 2024: 8Q3 2024Q4 2024: 15Q4 2024

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions9$86K
Exits3$384K

All 13F filers, Q3 2024 → Q4 2024: 311,295 shares bought and 160,713 shares sold, net +150,582 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 15 holders

Renaissance Technologies 0.00% New 119,266 $42K
UBS Group AG 0.00% Add +15303.4% 59,611 $21K
Geode Capital Management, LLC 0.00% New 59,167 $21K
XTX Topco Ltd 0.00% New 19,456 $7K
Two Sigma Investments, LP 0.00% New 14,449 $5K
Cubist Systematic Strategies, LLC 0.00% New 13,696 $5K
Goldman Sachs Group Inc. 0.00% New 12,326 $4K
HRT Financial LP 0.00% New 11,057 $3K
Tower Research Capital LLC (TRC) 0.00% Add +133.0% 4,521 $2K
Bank of America Corp. 0.00% Add +1650.0% 70 $24
SBI Securities Co., Ltd. 0.00% — 62 $22
BlackRock, Inc. 0.00% New 6 $2
Activest Wealth Management 0.00% No change 2 $1
Wells Fargo & Company 0.00% New 1 $0
Royal Bank of Canada 0.00% No change 2 $0

"% of holder's portfolio" is WINDTREE THERAPEUTICS INC's weight in each manager's 13F, not the share of Windtree Therapeutics Inc. the manager owns.